- Q3 2024 UPL Ltd Earnings Call TranscriptFeb 02, 2024$17.25Earnings
- Q2 2024 UPL Ltd Earnings Call TranscriptOct 30, 2023$17.25Earnings
- UPL Ltd Annual Shareholders Meeting TranscriptAug 18, 2023
- Q1 2024 UPL Ltd Earnings Call TranscriptJul 31, 2023$17.25Earnings
- UPL Ltd Extraordinary Shareholders Meeting TranscriptJul 20, 2023
- UPL Ltd Capital Markets Day TranscriptMay 08, 2023
- Q3 2023 UPL Ltd Earnings Call TranscriptJan 31, 2023Earnings
- Q2 2023 UPL Ltd Earnings Call TranscriptNov 01, 2022$17.3Earnings
- Q1 2023 UPL Ltd Earnings Call TranscriptAug 01, 2022$17.3Earnings
- UPL Ltd Capital Markets Day TranscriptMay 09, 2022
- Q3 2022 UPL Ltd Earnings Presentation TranscriptJan 31, 2022
- Q2 2022 UPL Ltd Earnings Call TranscriptOct 29, 2021Earnings
- UPL Ltd Annual Shareholders Meeting TranscriptAug 06, 2021
- Q1 2022 UPL Ltd Earnings Call TranscriptJul 30, 2021Earnings
- UPL Ltd Capital Markets Day TranscriptMay 12, 2021
- Q3 2021 UPL Ltd Earnings Call TranscriptJan 29, 2021Earnings
- UPL Ltd Discussing the Response to the Recent News Reports in the Media Call TranscriptDec 10, 2020
- Q2 2021 UPL Ltd Earnings Call TranscriptOct 30, 2020Earnings
- UPL Ltd Annual Shareholders Meeting TranscriptAug 31, 2020
- Q1 2021 UPL Ltd Earnings Call TranscriptJul 31, 2020Earnings
- UPL Ltd Capital Markets Day TranscriptMay 22, 2020
- Q3 2020 UPL Ltd Earnings Call TranscriptFeb 07, 2020Earnings
- Q2 2020 UPL Ltd Earnings Call TranscriptNov 07, 2019Earnings
- Q1 2020 UPL Ltd Earnings Call TranscriptJul 31, 2019Earnings
- UPL Ltd Capital Markets Day TranscriptMay 17, 2019
- Novozymes A/S to Discuss the Continuation of Partnership with Bayer AG and with Two New Partners, Univar Solutions and UPL Ltd Call TranscriptApr 05, 2019
UPL Ltd Capital Markets Day Transcript
Good afternoon. Good afternoon, ladies and gentlemen, and welcome to the UPL Capital Market Day.
Financial year '18-'19 has been a momentous year for UPL. As you all know, on 20th of July, we announced the acquisition of Arysta LifeScience for a total consideration of $4.2 billion. And in just 6.5 months, we have closed the transaction and started operating as one company effective 1st of February 2019. Besides this, this year, as some of you may know, is the 50th year of -- 50th year UPL has completed as the Golden Jubilee year. In today's Board meeting, the Board has approved issuance of bonus shares in the ratio of 1 share for every 2 shares held subject to the shareholders' approval.
With this, we move onto the agenda for the Capital Market Day. We start off with the presentation of Mr. Jai Shroff, followed by a presentation from Mr. Diego Casanello, who is our -- who was the CEO of Arysta LifeScience and is now the CEO (sic) [COO] of the combined entity. Followed by this presentation, you'll have a presentation from Carlos Pellicer, who -- I
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)